Q5152 Injection, eculizumab-aeeb, 2 milligrams
Q-Codes
Also known as: eculizumab biosimilar, C5 inhibitor, complement inhibitor
Injection of eculizumab-aeeb (Fabhalta), a biosimilar to eculizumab, administered at 2 milligrams per dose.
Clinical Context
Used for atypical hemolytic uremic syndrome and paroxysmal nocturnal hemoglobinuria management. Blocks complement component 5 activation and administration is intravenous.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.